Compare · SNX vs WGS
SNX vs WGS
Side-by-side comparison of TD SYNNEX Corporation (SNX) and GeneDx Holdings Corp. (WGS): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both SNX and WGS operate in Retail: Computer Software & Peripheral Equipment (Technology), so they compete in similar markets.
- SNX is the larger of the two at $21.28B, about 7.1x WGS ($3.02B).
- Over the past year, SNX is up 75.9% and WGS is down 22.3% - SNX leads by 98.2 points.
- WGS has been more active in the news (9 items in the past 4 weeks vs 3 for SNX).
- SNX has more recent analyst coverage (22 ratings vs 8 for WGS).
- Company
- TD SYNNEX Corporation
- GeneDx Holdings Corp.
- Price
- $266.17+0.67%
- $101.19-3.58%
- Market cap
- $21.28B
- $3.02B
- 1M return
- +5.62%
- +27.00%
- 1Y return
- +75.90%
- -22.32%
- Industry
- Retail: Computer Software & Peripheral Equipment
- Retail: Computer Software & Peripheral Equipment
- Exchange
- NYSE
- NASDAQ
- IPO
- 2003
- 2020
- News (4w)
- 3
- 9
- Recent ratings
- 22
- 8
TD SYNNEX Corporation
SYNNEX Corporation provides business process services in the United States and internationally. The company distributes peripherals; and information technology systems, including system components, software, networking, communications and security equipment, consumer electronics, and complementary products, as well as designs and integrates data center equipment. It also provides systems design and integration solutions, build-to-order, and configure-to-order assembly capabilities; logistics services that comprise outsourced fulfillment, virtual distribution, and direct ship to end-users; cloud services; online services; and financing services comprising net terms, third party leasing, floor plan financing, and letters of credit backed financing and arrangements. In addition, the company offers marketing services, such as direct mail, external media advertising, reseller product training, targeted telemarketing campaigns, trade shows, trade groups, database analysis, print on demand services, and web-based marketing. It serves resellers, system integrators, and retailers. The company was formerly known as SYNNEX Information Technologies, Inc. and changed its name to SYNNEX Corporation in October 2003. SYNNEX Corporation was founded in 1980 and is headquartered in Fremont, California.
Latest SNX
- Chair, Hyve Solutions Polk Dennis sold $660,477 worth of shares (2,500 units at $264.19) as part of a pre-agreed trading plan (SEC Form 4)
- Hammerhead AI and TD SYNNEX Announce Strategic Collaboration to Bring AI-Ready Power Capacity to Market
- TD SYNNEX to Announce Third Quarter Fiscal 2026 Results on September 24, 2026
- TD SYNNEX Strengthens PartnerFirst to Deliver More Data-Driven Partner Experiences
- Hyve Solutions Expands Manufacturing Footprint With Reno and North Las Vegas Campuses
- Chair, Hyve Solutions Polk Dennis sold $653,015 worth of shares (2,500 units at $261.21) as part of a pre-agreed trading plan (SEC Form 4)
- TD SYNNEX Expands IBM Distribution to Accelerate Partner-Led Growth Worldwide
- Director Hume Richard T sold $1,311,051 worth of shares (5,000 units at $262.21) as part of a pre-agreed trading plan, decreasing direct ownership by 27% to 13,537 units (SEC Form 4)
- Amendment: SEC Form SCHEDULE 13G/A filed by TD SYNNEX Corporation
- TD SYNNEX Earns 2026 Great Place to Work Certification™
Latest WGS
- CHIEF EXECUTIVE OFFICER Stueland Katherine converted options into 18,750 shares and sold $1,025,013 worth of shares (10,501 units at $97.61), increasing direct ownership by 8% to 115,476 units (SEC Form 4) (withholding obligation)
- CHIEF FINANCIAL OFFICER Feeley Kevin converted options into 7,197 shares and sold $363,892 worth of shares (3,728 units at $97.61), increasing direct ownership by 8% to 44,945 units (SEC Form 4) (tax withholding)
- Director Fuchs Thomas converted options into 1,146 shares (SEC Form 4)
- CHIEF EXECUTIVE OFFICER Stueland Katherine converted options into 6,547 shares and sold $310,932 worth of shares (3,692 units at $84.22), increasing direct ownership by 3% to 107,227 units (SEC Form 4) to cover taxes
- CHIEF FINANCIAL OFFICER Feeley Kevin converted options into 2,462 shares and sold $108,220 worth of shares (1,285 units at $84.22), increasing direct ownership by 3% to 41,476 units (SEC Form 4) to satisfy tax liability
- GeneDx and Beren Therapeutics Launch NPC GenomeComplete to Improve Diagnosis of Niemann-Pick Disease Type C
- CHIEF FINANCIAL OFFICER Feeley Kevin converted options into 717 shares and sold $31,188 worth of shares (372 units at $83.84), increasing direct ownership by 0.86% to 40,299 units (SEC Form 4) to cover taxes
- SEC Form 144 filed by GeneDx Holdings Corp.
- GeneDx CEO Katherine Stueland Recognized as a 2026 Fierce 50 Honoree
- GeneDx Announces Transformative Study Supporting Hospital-Wide Adoption of Rapid Genomic Sequencing at Seattle Children’s